Literature DB >> 17783671

Dopamine receptors and average clinical doses.

I Creese, D R Burt, S H Snyder.   

Abstract

Year:  1976        PMID： 17783671     DOI： 10.1126/science.194.4264.546

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  16 in total

1.  The dopamine antagonist cis-flupenthixol blocks the expression of the conditioned positive but not the negative effects of cocaine in rats.

Authors:  Jennifer M Wenzel; Zu-In Su; Kerisa Shelton; Hiram M Dominguez; Victoria A von Furstenberg; Aaron Ettenberg
Journal:  Pharmacol Biochem Behav       Date:  2013-09-05       Impact factor: 3.533

2.  Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levels.

Authors:  J C Baron; J L Martinot; H Cambon; J P Boulenger; M F Poirier; V Caillard; J Blin; J D Huret; C Loc'h; B Maziere
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 3.  Hippocampal dysregulation of dopamine system function and the pathophysiology of schizophrenia.

Authors:  Daniel J Lodge; Anthony A Grace
Journal:  Trends Pharmacol Sci       Date:  2011-06-21       Impact factor: 14.819

Review 4.  The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophrenia.

Authors:  Samuel M Cohen; Richard W Tsien; Donald C Goff; Michael M Halassa
Journal:  Schizophr Res       Date:  2015-01-09       Impact factor: 4.939

5.  Some neuropharmacological aspects of schizophrenia: a short review.

Authors:  B E Leonard; M Kenny
Journal:  Ir J Med Sci       Date:  1978-08       Impact factor: 1.568

Review 6.  Circuits and functions of the lateral habenula in health and in disease.

Authors:  Hailan Hu; Yihui Cui; Yan Yang
Journal:  Nat Rev Neurosci       Date:  2020-04-08       Impact factor: 34.870

7.  Protein Markers of Neurotransmitter Synthesis and Release in Postmortem Schizophrenia Substantia Nigra.

Authors:  Kirsten E Schoonover; Lesley A McCollum; Rosalinda C Roberts
Journal:  Neuropsychopharmacology       Date:  2016-08-23       Impact factor: 7.853

8.  Dopamine and non-dopamine psychoses.

Authors:  D L Garver; F Zemlan; J Hirschowitz; R Hitzemann; M L Mavroidis
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

Review 9.  Phosphorylation of the Amino Terminus of the Dopamine Transporter: Regulatory Mechanisms and Implications for Amphetamine Action.

Authors:  Caline S Karam; Jonathan A Javitch
Journal:  Adv Pharmacol       Date:  2017-10-25

10.  Hippocampal deep brain stimulation reverses physiological and behavioural deficits in a rodent model of schizophrenia.

Authors:  Stephanie M Perez; Amiksha Shah; Amber Asher; Daniel J Lodge
Journal:  Int J Neuropsychopharmacol       Date:  2012-11-28       Impact factor: 5.176
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.